Intake Forms for Psychologists: Clinical Assessment and Treatment Planning

By Daniel Akselrod · July 2026

A psychologist’s intake is not the same as a therapist’s intake. Both involve a clinical interview, both collect presenting concerns, and both ask about treatment history. But a psychologist — particularly one who does assessment, diagnostic formulation, or neuropsychological evaluation — needs intake documentation that goes substantially deeper than the standard biopsychosocial template most mental health professionals use. The difference is not just more questions. It is a different kind of question, aimed at a different kind of clinical decision.

A licensed clinical psychologist who is evaluating whether a patient’s cognitive complaints are early-stage neurodegenerative disease, depression-related pseudodementia, or the lingering effects of a traumatic brain injury from fifteen years ago needs intake data that no standard therapy form collects. A psychology intake form built for this level of practice captures the developmental, medical, and functional history that informs diagnostic formulation and test selection.

Standardized screening instruments at intake

Most therapy practices use a single screening tool at intake — a PHQ-9 for depression or a GAD-7 for anxiety — and that’s appropriate for their scope of practice. Psychology intake, especially in assessment-focused practices, often administers multiple brief screeners before the first session to guide the clinical interview and identify which formal test batteries to schedule:

• Mood and anxiety screeners — PHQ-9, GAD-7, and possibly the PCL-5 (PTSD Checklist) if trauma is indicated. These are quick, validated, and produce scores that become part of the baseline record. The scores at intake compared to scores at discharge are the most straightforward measure of treatment outcome.
• Cognitive screening — for patients referred for cognitive complaints, a brief cognitive screen (Montreal Cognitive Assessment, Mini-Mental State Examination, or similar) during intake establishes whether a full neuropsychological battery is warranted. These are clinician-administered, not self-report, and require specific training to score. Your intake form should include a field for the screening instrument used and the raw score, not just “cognitive concerns noted.”
• Substance use screening — the CAGE, AUDIT, or DAST-10, depending on the substance. Substance use complicates every diagnostic formulation. A patient presenting with anxiety symptoms who is drinking twelve drinks a week has a different clinical picture than one who does not drink at all. The screening score belongs in the intake record, not buried in session notes.
• Functional impairment measures — the WHODAS 2.0 (WHO Disability Assessment Schedule) or legacy GAF (Global Assessment of Functioning) score. These instruments quantify how much the patient’s symptoms interfere with daily life — work, relationships, self-care, community participation. Insurance companies increasingly require functional impairment documentation to authorize ongoing treatment, and a baseline score at intake is the foundation for that documentation.

Diagnostic formulation: beyond the checklist

A therapist identifies presenting problems. A psychologist formulates a differential diagnosis. The intake form should support that process:

• Previous diagnoses — list every prior diagnosis the patient has received, who made it, and when. A patient who was diagnosed with ADHD at age 8 by a pediatrician based on a parent questionnaire is different from one diagnosed at age 30 by a neuropsychologist after formal testing. The provenance of the diagnosis matters for your formulation.
• Previous psychological testing — has the patient undergone prior neuropsychological evaluation, psychoeducational testing, personality assessment (MMPI, PAI), or cognitive testing? When? By whom? What were the findings? Prior test results are critical because many cognitive and personality tests have practice effects — a patient who took the WAIS-IV six months ago should not be re-administered the same instrument. Your intake must identify prior testing to guide test selection.
• Symptom timeline — when did symptoms begin? Was onset gradual or sudden? Were there precipitating events? The difference between a patient whose depression began six weeks ago after a job loss and one who has been depressed “as long as I can remember” is the difference between adjustment disorder and persistent depressive disorder — and the treatment plan is different for each.
• Rule-out conditions — your intake should explicitly prompt the clinician to note conditions to rule out. A patient referred for “anxiety” may actually have a thyroid condition, cardiac arrhythmia, sleep apnea, or medication side effects producing anxiety-like symptoms. The rule-out list drives both the testing protocol and any medical referrals.

Neuropsychological and developmental history

For psychologists who conduct neuropsychological evaluations or work with developmental populations, the intake must capture history that most clinical forms skip entirely:

• Birth and perinatal history — premature birth, birth complications (anoxia, cord issues, emergency C-section), NICU stay, low birth weight. These events can have lifelong cognitive implications. A patient with a history of perinatal anoxia who presents with learning difficulties at age 25 has a different etiological picture than one with an unremarkable birth history.
• Developmental milestones — age of first words, first sentences, walking, toilet training. Delays in language or motor milestones may indicate developmental conditions (autism spectrum, specific learning disabilities, intellectual disability) that were never formally evaluated. Many adults seeking psychology services were children in an era when developmental screenings were less systematic.
• Academic history — special education services, IEP or 504 plan, grade retention, learning difficulties in specific subjects. A patient who received resource room services for reading in elementary school may have an undiagnosed specific learning disability that is now affecting job performance.
• Head injury and neurological history — every concussion, loss of consciousness, motor vehicle accident with head impact, fall, assault, or blast exposure (military). Document the approximate date, whether there was loss of consciousness and for how long, and whether the patient received medical evaluation at the time. Cumulative traumatic brain injury effects are not always obvious, and a thorough TBI history is essential for neuropsychological test interpretation.

Family psychiatric history

Genetics load the gun. Family history is the strongest predictor for many psychiatric conditions, and a thorough intake captures it systematically, not as an afterthought:

• First-degree relatives — parents and siblings. Document any known psychiatric diagnoses, substance use disorders, suicide attempts or completions, and psychiatric hospitalizations. A patient whose mother and maternal aunt both had bipolar disorder is at substantially elevated risk, and that risk factor should be visible in the intake record, not discovered in session three.
• Second-degree relatives — grandparents, aunts, uncles. Broader family psychiatric history can reveal patterns the patient may not recognize — multiple family members with “bad nerves” or “drinking problems” may indicate a heritable vulnerability that informs your diagnostic formulation.
• Family history of neurodegenerative conditions — particularly relevant for patients presenting with cognitive complaints. A family history of Alzheimer’s disease, frontotemporal dementia, or Parkinson’s disease changes the urgency and scope of the neuropsychological evaluation.

Trauma exposure screening

Trauma history requires its own dedicated section, not a single checkbox. Many patients do not disclose trauma spontaneously, and a structured screening is more effective:

• Trauma types — childhood physical, sexual, or emotional abuse; neglect; domestic violence (witnessed or experienced); sexual assault; combat exposure; serious accident; natural disaster; sudden unexpected death of a close person; medical trauma. Each type has different clinical implications and may indicate different assessment instruments (ACE questionnaire for childhood adversity, PCL-5 for PTSD, DES-II for dissociation).
• Age at exposure — trauma experienced before age 5, during latency, during adolescence, or in adulthood affects both symptom presentation and treatment approach. Early childhood trauma is more likely to produce complex PTSD, attachment disturbance, and personality pathology than a single-incident adult trauma.
• Prior trauma treatment — has the patient received trauma-focused therapy before (CPT, PE, EMDR)? What was the outcome? A patient who completed a full course of CPT and continues to have PTSD symptoms may need a different approach than one who has never had trauma-specific treatment.

Informed consent for psychological testing

This is where psychology intake has a documentation requirement that therapy intake does not. If you plan to administer formal psychological or neuropsychological tests, the patient must provide informed consent specifically for testing — separate from consent for treatment:

• Purpose of testing — what diagnostic question is being answered? What decisions will be informed by the results?
• Nature of the evaluation — how long will testing take (often 4 to 8 hours for a full neuropsychological battery), what will the patient be asked to do, and will there be breaks?
• Who will receive the report — the referring provider, the insurance company, an attorney (in forensic cases), a school district. The patient should know who sees the results before testing begins.
• Limitations — testing provides diagnostic impressions, not certainties. Results can be affected by effort, medication, sleep, fatigue, and state anxiety. The consent should note these limitations.

Insurance pre-authorization

Psychological testing is one of the most commonly denied services in behavioral health insurance. Your intake should capture the information needed to request pre-authorization before scheduling the testing appointment:

• Insurance carrier and plan type — HMO, PPO, EPO, or Medicaid/Medicare. Some plans cover neuropsychological testing with no prior authorization. Others require a letter of medical necessity from the referring physician. Some exclude it entirely.
• Referring provider — who referred the patient and what was the referral question? Authorization requests require a specific clinical question, not “patient requested testing.”
• CPT codes anticipated — 96136/96137 (psychological testing), 96132/96133 (neuropsychological testing), 96130/96131 (evaluation services). Knowing which codes you plan to bill lets your administrative staff request authorization for the right service before testing day.

Psychology intake forms carry a documentation burden that reflects the diagnostic and assessment responsibilities of the profession. A form that captures screening scores, developmental history, prior testing, family psychiatric patterns, trauma exposure, and testing consent gives the clinician a complete foundation for the evaluation — and gives the billing department what they need to get the service authorized and paid.